Sanaplasma s.r.o. focuses on source plasma-collection through its operation of 14 European plasmapheresis centers; 11 in the Czech Republic and 3 in Hungary. Sanaplasma s.r.o. was recently acquired by Takeda, a leading global biopharmaceutical company, and operates as part of the Takeda BioLife plasma center division We as a part of the Takeda/Bio Life family, are committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Our R&D efforts are focused on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. https://sanaplasma.cz/ https://www.takeda.com/who-we-are/ .
